Supporting the role of ATM as a tumor suppressor in cancer, a high frequency of loss of heterozygosity at 11q22‐q23 (a locus that includes ATM) is observed in female breast cancer 45 and a high frequency of ATM LOF mutations is found in T‐cell prolymphocytic leukemia (T‐PLL) 46. Here, ATM is linked to breast carcinoma.